Basic Stats
LEI | 549300SBSSIZUVSY4U27 |
CIK | 1769484 |
SEC Filings
SEC Filings (Chronological Order)
September 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
August 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
June 20, 2025 |
Bioceres Crop Solutions Announces Changes to Board of Directors Exhibit 99.1 Bioceres Crop Solutions Announces Changes to Board of Directors ROSARIO, Argentina - 06/20/2025 - Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, today announced changes to the composition of its B |
|
June 20, 2025 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2025 and June 30, 2024, and for the three- and nine-month periods ended March 31, 2025 and 2024. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2025 and June 30, 2024, and for the three- and nine-month peri |
|
June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
June 20, 2025 |
FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES Exhibit 99.1 FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES This First Amendment to Note Purchase Agreement and the Notes (this “Agreement”), dated as of June 18, 2025, is made by and among Jasper Lake Ventures One LLC, Redwood Enhanced Income Corp. and Liminality Partners LP (collectively, the "Purchasers" and each a “Purchaser”), Bioceres Crop Solutions Corp., an exempted company incorpora |
|
June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
June 20, 2025 |
FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES Exhibit 99.2 FIRST AMENDMENT TO NOTE PURCHASE AGREEMENT AND NOTES This First Amendment to Note Purchase Agreement and the Notes (this “Agreement”), dated as of June 18, 2025, is made by and among Solel-Bioceres SPV, L.P. (the “Purchaser”), Bioceres Crop Solutions Corp., an exempted company incorporated under the laws of the Cayman Islands (the “Issuer”) and Wilmington Savings Fund Society, FSB, in |
|
May 21, 2025 |
Contact Bioceres Crop Solutions Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results Total revenues in 3Q25 were $60.6 million 3Q25 net loss was $1.6 million and Adjusted EBITDA1 was $9.0 million ROSARIO, Argentina – May 21, 2025 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity s |
|
May 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
March 11, 2025 |
Exhibit 99.1 Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management ROSARIO, Argentina—March 11, 2025 (BUSINESS WIRE) —Bioceres Crop Solutions (NASDAQ: BIOX), a leading global provider of sustainable crop productivity solutions, and ProFarm Group, a subsidiary of BIOX, today announced that their inn |
|
March 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
March 6, 2025 |
Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042 Exhibit 99.1 Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042 ROSARIO, Argentina—March 5, 2025 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX), announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-ØØ412-7. This approval |
|
March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
February 28, 2025 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2024 and June 30, 2024, and for the three- and six-month periods ended December 31, 2024 and 2023. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2024 and June 30, 2024, and for the three- and six-mon |
|
February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 14, 2025 |
Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew. |
|
February 12, 2025 |
Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Second Quarter 2025 Financial and Operational Results Total revenues in 2Q25 were $106.7 million 2Q25 net income was $0.6 million and Adjusted EBITDA1 was $15.4 million ROSARIO, Argentina – February 11, 2025 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of prod |
|
February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 6, 2025 |
Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations Exhibit 99.1 Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations Rosario, Argentina – February 5, 2025 – Bioceres Crop Solutions Corp. (NASDAQ: BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million, with gross profit of $45 million |
|
January 22, 2025 |
Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-284195 PROSPECTUS Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) This prospectus relates to the resale, from time to time, of (i) 8,434 ordinary shares, par value $0.0001 per share (“Ordinary Shares”) of Bioceres Crop Solutions Corp., previously registered pursuant to our registration on Form F-1 (File No |
|
January 17, 2025 |
As filed with the Securities and Exchange Commission on January 17, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 17, 2025 Registration No. |
|
January 17, 2025 |
January 17, 2025 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the “Company”) Acceleration Request for Registration Statement on Form F-3 (File No. 333-284195), as amended by Pre-Effective Amendment No. 1 Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, the Company hereby requests t |
|
January 10, 2025 |
As filed with the Securities and Exchange Commission on January 10, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 10, 2025 Registration No. |
|
January 10, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp. |
|
December 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 27, 2024 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2024 and June 30, 2024, and for the three- month periods ended September 30, 2024 and 2023. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2024 and June 30, 2024, and for the three-month periods end |
|
November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 12, 2024 |
Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results Total revenues in 1Q25 were $93.3 million 1Q25 net loss1 was $5.3 million and Adjusted EBITDA1 was $8.5 million ROSARIO, Argentina – November 11, 2024 – Bioceres Crop Solutions Corp. (“Bioceres” or the “Company”) (NASDAQ: BIOX), a leader in the development and commercial |
|
October 30, 2024 |
NASDAQ EXECUTIVE REMUNERATION CLAWBACK POLICY Exhibit 97 NASDAQ EXECUTIVE REMUNERATION CLAWBACK POLICY 1 PURPOSE 1.1 The purpose of this policy (this “Nasdaq Clawback Policy”) is to set out the basis for the mandatory recovery of erroneously awarded Incentive-Based Compensation (as defined below) from Executives (as defined below) of Bioceres Crop Solutions Corp. (the “Company”, together with its subsidiaries, the “Group“) in the event of a R |
|
October 30, 2024 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 |
|
October 30, 2024 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 |
|
October 30, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Registration No.333-272280) and Form S-8 (Registration Nos. 333-255635, 333-266333 and 333-271941) of our report dated October 30, 2024 relating to the financial statements and the effectiveness of internal control over financial repo |
|
October 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEC |
|
October 30, 2024 |
Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi |
|
October 30, 2024 |
Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Enrique López Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o |
|
October 23, 2024 |
SC 13G 1 bioxonnasdaq101124.htm FOURTH SAIL CAPITAL LP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares (Title of Class of Securities) G1117K114 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate bo |
|
October 3, 2024 |
Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] October 3, 2024 Dear Shareholder, You are cordially invited to attend the 2024 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m. EDT on October 24, 2024 at the Compan |
|
October 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
September 30, 2024 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of June 30, 2024 and 2023 and for the years ended June 30, 2024, 2023 and 2022. INDEX Consolidated financial statements as of June 30, 2024 and 2023 and for the years ended June 30, 2024, 2023 and 2022. Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-5 Consoli |
|
September 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
September 20, 2024 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres Group PLC - SC 13D/A Activist Investment SC 13D/A 1 tm2424494d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Bioceres Group PLC Highdown House, Yeoman Way, |
|
September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
September 10, 2024 |
Contact Bioceres Crop Solutions Exhibit 99.1 Bioceres Crop Solutions Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2024 Financial and Operational Results Revenues up 18% in 4Q24, consolidating annual revenues of $465 million FY24 GAAP net income at $6.2 million and adjusted EBITDA1 at $81.4 million ROSARIO, Argentina – September 9, 2024 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in |
|
August 28, 2024 |
Exhibit 99.1 Bioceres Crop Solutions receives green light for cultivation of drought tolerant hb4 wheat in the United StATES ROSARIO, Argentina—August 28, 2024 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced today that the United States Department of Agriculture (USDA) has favorably concluded its Regulatory Status Review (RSR) for HB4 wheat technology. The announcement can |
|
August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 29, 2024 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2024 and June 30, 2023, and for the three and nine month periods ended March 31, 2024 and 2023. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2024 and June 30, 2023, and for the three and nine month period |
|
May 14, 2024 |
FISCAL THIRD QUARTER Financial and Operating Results Exhibit 99.1 FISCAL THIRD QUARTER 2024 Financial and Operating Results BIOCERES CROP SOLUTIONS THIRD QUARTER 2024 Bioceres Crop Solutions Reports Fiscal Third Quarter 2024 Financial and Operational Results Total revenues in 3Q24 were $84.0 million 3Q24 GAAP net income was $9.8 million and adjusted EBITDA1 was $21.1 million ROSARIO, Argentina – May 13, 2024 – Bioceres Crop Solutions Corp. (Bioceres |
|
May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 7, 2024 |
Bioceres Crop Solutions Announces Brazil’s Approval of New Generation Bio-Insecticide Exhibit 99.1 Bioceres Crop Solutions Announces Brazil’s Approval of New Generation Bio-Insecticide LONDRINA, Brazil—May 7, 2024 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX), announced today the approval by Brazil’s Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cell |
|
May 2, 2024 |
Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew. |
|
April 11, 2024 |
Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew. |
|
March 25, 2024 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres Group PLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 9)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Bioceres Group PLC Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom Tele |
|
March 25, 2024 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl |
|
March 1, 2024 |
Linklaters LLP 1290 Avenue of the Americas New York, NY 10104 Telephone (+1) 212 903 9000 Facsimile (+1) 212 903 9100 matthew. |
|
February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 28, 2024 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three and six month periods ended December 31, 2023 and 2022. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three and six month |
|
February 14, 2024 |
BIOX / Bioceres Crop Solutions Corp. / Solel Partners LP - SC 13G/A Passive Investment SC 13G/A 1 ef20021543sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * BIOCERES CROP SOLUTIONS CORP. ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G1117K114 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check t |
|
February 9, 2024 |
FISCAL SECOND QUARTER Financial and Operating Results Exhibit 99.1 FISCAL SECOND QUARTER 2024 Financial and Operating Results BIOCERES CROP SOLUTIONS SECOND QUARTER 2024 Bioceres Crop Solutions Reports Fiscal Second Quarter 2024 Financial and Operational Results 2Q24 revenues at $140.2 million, 49% higher YoY GAAP net income at $1.2 million, and adjusted EBITDA1 at $24.1 million ROSARIO, Argentina – February 8, 2024 – Bioceres Crop Solutions Corp. (B |
|
February 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
January 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2024 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
January 24, 2024 |
Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report Exhibit 99.1 Bioceres Crop Solutions Releases Scope 1 & 2 Greenhouse Gas Emissions Report ROSARIO, Argentina—January 23, 2024 (BUSINESS WIRE) —Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced today the release of the |
|
November 29, 2023 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three-month periods ended September 30, 2023 and 2022. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three-month periods ende |
|
November 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 29, 2023 |
Unaudited Consolidated Statement of Financial Position Exhibit 99.1 Unaudited Consolidated Statement of Financial Position (Figures in million of U.S. dollars) ASSETS 09/30/2023 06/30/2023 CURRENT ASSETS Cash and cash equivalents 28.4 48.1 Other financial assets 14.6 12.1 Trade receivables 186.3 158.0 Other receivables 24.9 28.8 Income and minimum presumed income taxes recoverable 2.0 9.4 Inventories 138.1 140.4 Biological assets 1.1 0.1 Total current |
|
November 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province o |
|
November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 14, 2023 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 |
|
November 14, 2023 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 |
|
November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
|
November 14, 2023 |
Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Enrique López Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o |
|
November 14, 2023 |
Exhibit 99.1 FISCAL FIRST QUARTER 2024 Financial and Operating Results BIOCERES CROP SOLUTIONS FIRST QUARTER 2024 1 Bioceres Crop Solutions Reports Fiscal First Quarter 2024 Financial and Operational Results 1Q24 revenues at $116.6 million, and adjusted EBITDA at $16.3 million Groundbreaking patent obtained in key product category ROSARIO, Argentina – November 13, 2023 – Bioceres Crop Solutions Co |
|
November 14, 2023 |
Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi |
|
November 14, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Registration No.333-272280) and Form S-8 (Registration Nos. 333-255635, 333-266333 and 333-271941) of our report dated November 14, 2023 relating to the financial statements and the effectiveness of internal control over financial rep |
|
October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K x Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form N-SAR ¨ Form N-CSR SEC FILE NUMBER 001-38405 CUSIP NUMBER G1117K114 For Period Ended: June 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report o |
|
October 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of |
|
October 12, 2023 |
Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] / [email protected] October 12, 2023 Dear Shareholder, You are cordially invited to attend the 2023 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m. |
|
October 11, 2023 |
Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] / [email protected] October 11, 2023 Dear Shareholder, You are cordially invited to attend the 2023 Annual General Meeting (the “Annual General Meeting”) of Bioceres Crop Solutions Corp. (the “Company”) to be held at 10:00 a.m. |
|
October 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
September 29, 2023 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2023, 2022 and 2021. Table of Contents INDEX Consolidated financial statements as of and for the years ended June 30, 2023, 2022 and 2021. Report of independent registered public accounting firm F-2 Consolidated statements of financial position F-3 Consolidated stat |
|
September 11, 2023 |
Exhibit 99.1 FISCAL FOURTH QUARTER & FULL YEAR 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS FOURTH QUARTER 2023 1 Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full Year 2023 Financial and Operational Results FY23 revenues up 25% and Adjusted EBITDA at $81.1 million ROSARIO, Argentina – September 11, 2023 – Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a lead |
|
September 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
July 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
July 18, 2023 |
Exhibit 99.1 Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe The Companies Signed an Exclusive Agreement on Distribution of Innovative Bioinsecticide GENEVA, Switzerland; ROSARIO, Argentina ‒ July 18, 2023 ‒ Corteva Agriscience (Corteva) (NYSE: CTVA) and Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), announced today that they have entered |
|
June 8, 2023 |
Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-272280 PROSPECTUS Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) This prospectus relates to the resale, from time to time, of (i) 14,759 ordinary shares, par value $0.0001 per share (“Ordinary Shares”) of Bioceres Crop Solutions Corp., previously registered pursuant to our registration on Form F |
|
June 6, 2023 |
June 6, 2023 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the “Company”) Acceleration Request for Registration Statement on Form F-3 (File No. 333-272280) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date of the above-referenced Registratio |
|
May 30, 2023 |
As filed with the Securities and Exchange Commission on May 30, 2023 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 30, 2023 Registration No. |
|
May 30, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp. |
|
May 24, 2023 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2023 and June 30, 2022, and for the three and nine-month periods ended March 31, 2023, and 2022. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2023, June 30, 2022 and for the three and nine-month periods e |
|
May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 15, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Bioceres Crop Solutions Corp. |
|
May 15, 2023 |
2023 Omnibus Equity Incentive Plan. Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. 2023 OMNIBUS EQUITY INCENTIVE PLAN WHEREAS, the Bioceres Crop Solutions Corp. 2023 Omnibus Equity Incentive Plan (this “Plan”) was established in order to provide an incentive to eligible employees of Bioceres Crop Solutions Corp., an exempted company incorporated under the laws of Cayman Islands (the “Company”) and its Subsidiaries; WHEREAS, the Company |
|
May 15, 2023 |
As filed with the Securities and Exchange Commission on May 15, 2023 As filed with the Securities and Exchange Commission on May 15, 2023 Registration No. |
|
May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 11, 2023 |
FISCAL THIRD QUARTER Financial and Operating Results Exhibit 99.1 FISCAL THIRD QUARTER 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS THIRD QUARTER 2023 Bioceres Crop Solutions Reports Fiscal Third Quarter 2023 Financial and Operational Results Revenues increased 33% compared with 3Q22 pro forma numbers LTM adjusted EBITDA reached $85.3 million Brazil HB4 initiatives advancing favorably on the back of full regulatory approval for wheat |
|
April 5, 2023 |
Bioceres Crop Solutions Releases FY22 Sustainability Report Exhibit 99.1 Bioceres Crop Solutions Releases FY22 Sustainability Report ROSARIO, Argentina – April 3, 2023 – Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, is pleased to announce the release of the company’s inaugural FY22 Sustainability Report, entitled: Each Step |
|
April 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
March 27, 2023 |
our Report on Form 6-K (File No. 001-38836), furnished to the SEC on March 27, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
March 27, 2023 |
Selected Unaudited Pro Forma Condensed Combined Financial Information Exhibit 99.1 Selected Unaudited Pro Forma Condensed Combined Financial Information The following unaudited pro forma combined financial information has been derived by the application of pro forma adjustments to the historical financial statements of BIOX, which were presented to give effect to the merger. The unaudited pro forma combined financial information has used the acquisition method of ac |
|
February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 28, 2023 |
Table of Contents Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2022 and June 30, 2022, and for the three and six month periods ended December 31, 2022, and 2021. Table of Contents INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2022, June 30, 2022 and for the three and six month pe |
|
February 14, 2023 |
BIOX / Bioceres Crop Solutions Corp. / Solel Partners LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* BIOCERES CROP SOLUTIONS CORP. ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G1117K114 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
February 9, 2023 |
Exhibit 99.1 FISCAL SECOND QUARTER 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS SECOND QUARTER 2023 1 Bioceres Crop Solutions Reports Fiscal Second Quarter 2023 Financial and Operational Results Severe drought in Argentina temporarily interrupted growth trajectory; decline in Argentina partially offset by higher sales in North America HB4 Wheat outperformed top commercial varieties |
|
February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 9, 2023 |
our Report on Form 6-K (File No. 001-38836), furnished to the SEC on February 9, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2023 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
January 25, 2023 |
EX-1 2 ex1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G (including amendments thereto) with respect to the Common Stock of Bioceres Crop Solutions Corp. and further agree that this Joint Filing Agreement be includ |
|
January 25, 2023 |
BIOX / Bioceres Crop Solutions Corp. / ARDSLEY ADVISORY PARTNERS LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Bioceres Crop Solutions Corp. (Name of Issuer) Common Stock (Title of Class of Securities) G1117K114 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
January 25, 2023 |
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP EX-2 3 ex2.htm EXHIBIT 2 EXHIBIT 2 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP ARDSLEY ADVISORY PARTNERS LP ARDSLEY ADVISORY PARTNERS GP LLC ARDSLEY PARTNERS I GP LLC PHILLIP J. HEMPLEMAN ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P. |
|
November 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 29, 2022 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2022 and June 30, 2022, and for the three-month periods ended September 30, 2022, and 2021. INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2022, June 30, 2022 and for the three-month periods ended September 30, 2022 and 2021. Unaudite |
|
November 18, 2022 |
BIOX / Bioceres Crop Solutions Corp. / DRACO Capital Investment Management Co Ltd Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
November 18, 2022 |
Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-268144 Bioceres Crop Solutions Corp. (incorporated in the Cayman Islands) This prospectus relates to the resale, from time to time, of (i) 4,755,684 ordinary shares, par value $0.0001 per share (?ordinary shares?) of Bioceres Crop Solutions Corp., (ii) 14,759 ordinary shares previously registered pursuant to our registration on Form |
|
November 17, 2022 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina Telephone: +54 0341 4 |
|
November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 14, 2022 |
November 14, 2022 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the ?Company?) Acceleration Request for Registration Statement on Form F-3 (File No. 333-268144) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date of the above-referenced Regist |
|
November 14, 2022 |
Exhibit 99.1 FISCAL FIRST QUARTER 2023 Financial and Operating Results BIOCERES CROP SOLUTIONS F IRST QUARTER 202 3 1 Bioceres Crop Solutions Reports Fiscal F irst Quarter 202 3 Financial and Operational Results R evenues increased 7 1 % compared to 1Q22 pro forma numbers 1Q23 Adjusted EBITDA nearly doubled YoY , reach ing $73 million on an LTM basis after excluding HB4 pre - launch costs A nnounc |
|
November 3, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) Bioceres Crop Solutions Corp. |
|
November 3, 2022 |
Form F-3 (Registration No. 333-268144) As filed with the Securities and Exchange Commission on November 3, 2022 Registration No. |
|
November 2, 2022 |
As filed with the Securities and Exchange Commission on November 2, 2022 As filed with the Securities and Exchange Commission on November 2, 2022 Registration No. |
|
November 2, 2022 |
BIOX’s Report on Form 6-K (File No. 001-38836), filed with the SEC on November 2, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 2, 2022 |
Form S-8 (Registration Nos. 333-255635 As filed with the Securities and Exchange Commission on November 2, 2021 Registration No. |
|
October 28, 2022 |
18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 |
|
October 28, 2022 |
Exhibit 15.2 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT We consent to the incorporation by reference in the Registration Statement of Bioceres Crop Solutions Corp. on Form 20-F, of our report, dated March 30, 2022, which includes an explanatory paragraph as to Pro Farm Group, Inc.’s (formerly known as Marrone Bio Innovations, Inc.) ability to continue as a going concern, with respect |
|
October 28, 2022 |
Exhibit 4.14 Registration Rights Agreement This Registration Rights Agreement, dated as of August 5, 2022 (as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is made by and among BIOCERES CROP SOLUTIONS CORP., a Cayman Islands exempted company (the “Company”), Jasper Lake Ventures One LLC (“Jasper”), Redwood Capital Ma |
|
October 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
|
October 28, 2022 |
18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Bioceres Crop Solutions Corp. (the “Company”) on Form 20-F for the year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 |
|
October 28, 2022 |
Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Executive Officer Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omi |
|
October 28, 2022 |
Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-249770) and Form S-8 (No. 333-255635 and 333-266333) of Bioceres Crop Solutions Corp. of our report dated September 30, 2022 relating to the financial statements, which appears in this Form 20-F. /s/ Price Waterhouse & Co. S.R |
|
October 28, 2022 |
Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Financial Officer Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Enrique López Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o |
|
October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
October 3, 2022 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 2020. INDEX Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 2020. Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-4 Consolidated statements of comprehensive income F-6 C |
|
September 30, 2022 |
6-K 1 tm2226809d26k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosa |
|
September 30, 2022 |
[This page has been intentionally left blank.] Exhibit 99.1 www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: +1 602 930 7022 E: [email protected] / [email protected] September 30, 2022 Dear Shareholder, You are cordially invited to attend the 2022 Annual General Meeting (the ?Annual General Meeting?) of Bioceres Crop Solutions Corp. (the ?Company? or ?Bioceres Crop Soluti |
|
September 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
September 16, 2022 |
Exhibit 99.1 Media Release Syngenta AG Bioceres Crop Solutions Rosentalstrasse 67 Ocampo 210 bis, Predio CCT 4002 Basel, Switzerland Rosario 2000, Argentina www.syngenta.com www.biocerescrops.com Syngenta Seedcare and Bioceres Crop Solutions collaborate to bring innovative biological seed treatments to market ? Syngenta Seedcare to become the exclusive commercialization distributor of Bioceres?s b |
|
September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
August 9, 2022 |
Exhibit 99.1 Bioceres Crop Solutions Executed Previously Announced Financing Agreements for a Total Amount of $79 Million ROSARIO, Argentina ? August 9, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (?Bioceres? or the ?Company?), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, has finalized and executed th |
|
August 8, 2022 |
Exhibit 99.9 NOTE PURCHASE AGREEMENT by and among BIOCERES CROP SOLUTIONS CORP., as Issuer, Solel-Bioceres SPV, L.P., as an Initial Purchaser, THE OTHER HOLDERS FROM TIME TO TIME PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB as Collateral Agent Dated as of August 5, 2022 Article 1. DEFINITIONS 1 1.1 Definitions 1 1.2 Terms Generally 26 1.3 Accounting Terms 26 Article 2. PURCHASE AND SALE O |
|
August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
August 8, 2022 |
Exhibit 99.10 Execution Version NOTE PURCHASE AGREEMENT by and among BIOCERES CROP SOLUTIONS CORP., as Issuer, and THE INITIAL PURCHASERS AND OTHER HOLDERS FROM TIME TO TIME PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB as Collateral Agent Dated as of August 5, 2022 Article 1. DEFINITIONS 1 1.1 Definitions 1 1.2 Terms Generally 27 1.3 Accounting Terms 27 Article 2. PURCHASE AND SALE OF THE |
|
August 4, 2022 |
BIOX / Bioceres Crop Solutions Corp. / DRACO Capital Investment Management Co Ltd Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
July 26, 2022 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. 2013 STOCK INCENTIVE PLAN, AS AMENDED (FORMERLY KNOWN AS THE ?MARRONE BIO INNOVATIONS, INC. 2013 STOCK INCENTIVE PLAN?) 1. Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company?s business. 2. |
|
July 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? ? ? FORM?S-8 REGISTRATION STATEMENT? UNDER THE SECURITIES ACT OF 1933 ? ? ? Bioceres Crop Solutions Corp. (Exact name of registrant as specified in its charter) ? ? ? Cayman Islands (State or other jurisdiction of incorporation or organization) N/A (I.R.S. Employer Identification No.) ? Ocampo 210 bis, Predio CCT, Rosari |
|
July 26, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) BIOCERES CROP SOLUTIONS CORP. |
|
July 25, 2022 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 7)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a |
|
July 25, 2022 |
Joint Filing Agreement, by and among the Reporting Persons Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl |
|
July 15, 2022 |
BIOX / Bioceres Crop Solutions Corp. / Ospraie Ag Science LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, par value US$0.0001 per share (Title of Class of Securities) G1117K114 (CUSIP Number) July 12, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
July 12, 2022 |
Form 6-K filed with the Commission on July 12, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
July 12, 2022 |
Exhibit 99.1 Bioceres Crop Solutions completes merger with Marrone Bio, creating a global leader in sustainable agricultural solutions ROSARIO, Argentina ? July 12, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (?Bioceres? or the ?Company?), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today t |
|
June 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of June 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (A |
|
June 27, 2022 |
FDA Favorably Concludes HB4® Wheat Food and Feed Safety Evaluation Exhibit 99.1 FDA Favorably Concludes HB4? Wheat Food and Feed Safety Evaluation ROSARIO, Argentina ? June 27, 2022 ? Bioceres Crop Solutions Corp. (?Bioceres? or the ?Company?) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that the U.S. Food and Drug Administration (FDA) has con |
|
June 9, 2022 |
LETTER TO STOCKHOLDERS OF MARRONE BIO INNOVATIONS, INC. TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(2)? ?Registration No. 333-264806? LETTER TO STOCKHOLDERS OF MARRONE BIO INNOVATIONS, INC. Dear Stockholders: Marrone Bio Innovations, Inc. (which we refer to as ?MBI?) and Bioceres Crop Solutions Corp. (which we refer to as ?BIOX?) have entered into a merger agreement (which, as it may be amended from time to time, we refer to as the ?merger agreeme |
|
June 6, 2022 |
Exhibit 99.1 CONSENT OF HOULIHAN LOKEY CAPITAL, INC. June 6, 2022 Marrone Bio Innovations, Inc. 7780-420 Brier Creek Parkway Raleigh, NC 27617 Attention: Board of Directors RE: Proxy Statement of Marrone Bio Innovations, Inc. (?MBI?) / Prospectus of Bioceres Crop Solutions Corp. (?BIOX?) which forms part of Amendment No. 1 to the Registration Statement on Form F-4 of BIOX (the ?Registration Statem |
|
June 6, 2022 |
Form of Proxy Card for Marrone Bio Innovations, Inc.’s Stockholder Meeting. Exhibit 99.2 |
|
June 6, 2022 |
June 6, 2022 U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Re: Bioceres Crop Solutions Corp. (the ?Company?) Acceleration Request for Registration Statement on Form F-4, as amended (File No. 333-264806) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date of the above-referenced |
|
June 6, 2022 |
As filed with the Securities and Exchange Commission on June 6, 2022. TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 6, 2022. |
|
May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 27, 2022 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2022 and June 30, 2021, and for the three-and nine-month periods ended March 31, 2022, and 2021. INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2022, June 30, 2021 and for the three and nine-month periods ended March 31, 2022 and 2021. Unaudi |
|
May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
May 9, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form F-4 (Form Type) BIOCERES CROP SOLUTIONS CORP. |
|
May 9, 2022 |
Form of Proxy Card for Marrone Bio Innovations, Inc.’s Stockholder Meeting. Exhibit 99.2 MARRONE BIO INNOVATIONS, INC. 7780-420 Brier Creek Parkway, Raleigh, NC 27617 VOTE BY INTERNET ? Before The Meeting - Go www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on [?], 2022 for shares held directly and by 11:59 p.m. Eastern Time on [?], 2022 for shares held in a Plan. Have your |
|
May 9, 2022 |
Exhibit 99.1 CONSENT OF HOULIHAN LOKEY CAPITAL, INC. May 9, 2022 Marrone Bio Innovations, Inc. 7780-420 Brier Creek Parkway Raleigh, NC 27617 Attention: Board of Directors RE: Proxy Statement of Marrone Bio Innovations, Inc. (?MBI?) / Prospectus of Bioceres Crop Solutions Corp. (?BIOX?) which forms part of the Registration Statement on Form F-4 of BIOX (the ?Registration Statement?). Dear Members |
|
May 9, 2022 |
As filed with the Securities and Exchange Commission on May 9, 2022. As filed with the Securities and Exchange Commission on May 9, 2022. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bioceres Crop Solutions Corp. (Exact name of Registrant as Specified in its articles of association)* N/A (Translation of registrant name into English) Cayman Isl |
|
April 29, 2022 |
Exhibit 99.1 Bioceres Crop Solutions Announces Regulatory Approval of HB4? Soy in China China?s Ministry of Agriculture clearance enables import of soybeans produced using Bioceres? drought tolerance HB4? technology ROSARIO, Argentina April 29, 2022 - Bioceres Crop Solutions Corp. (?Bioceres? or the ?Company?) (NASDAQ: BIOX), a fully-integrated global provider of crop productivity solutions design |
|
April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
April 5, 2022 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl |
|
April 5, 2022 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a |
|
March 23, 2022 |
Filed by Marrone Bio Innovations, Inc. Filed by Marrone Bio Innovations, Inc. (Commission File No. 001-36030) Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed under Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Marrone Bio Innovations, Inc. (Commission File No.: 001-36030) Date: March 18, 2022 The following is a transcript of a conference presentation that was given |
|
March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
March 17, 2022 |
425 1 tm229590d2425.htm 425 Filed by Bioceres Crop Solutions Corp. (Commission File No. 001-38836) Pursuant to Rule 425 under the Securities Act of 1933 And Deemed Filed under Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Bioceres Crop Solutions Corp. 0800 138 2636 | [email protected] Transcript www.incommglobal.com Bioceres Crop Solutions Corporate Update Thursday, |
|
March 17, 2022 |
Exhibit 99.2 Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible notes into shares and new term loan facility ROSARIO, Argentina, and RALEIGH, N.C. ? March 16, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ: |
|
March 17, 2022 |
Exhibit 2.1 CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among Bioceres Crop Solutions Corp., BCS Merger Sub, Inc. and Marrone Bio Innovations, Inc. Dated as of March 16, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 2 Section 1.01 Certain Definitions 2 Section 1.02 Additional Definitions 16 Section 1.03 Certain Interpretations 19 ARTICLE II THE MERGER 20 Section 2.01 The |
|
March 17, 2022 |
Exhibit 2.1 CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among Bioceres Crop Solutions Corp., BCS Merger Sub, Inc. and Marrone Bio Innovations, Inc. Dated as of March 16, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS & INTERPRETATIONS 2 Section 1.01 Certain Definitions 2 Section 1.02 Additional Definitions 16 Section 1.03 Certain Interpretations 19 ARTICLE II THE MERGER 20 Section 2.01 The |
|
March 17, 2022 |
Transaction Support Agreement for Company Securityholders Exhibit 99.1 Transaction Support Agreement for Company Securityholders This Transaction Support Agreement (this ?Agreement?) is made and entered into as of March 16, 2022, by and among Bioceres Crop Solutions Corp., a Cayman Islands exempted company (?Parent?), BCS Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (?Merger Sub?), and the stockholders of Marrone Bio I |
|
March 17, 2022 |
Transaction Support Agreement for Company Securityholders Exhibit 99.1 Transaction Support Agreement for Company Securityholders This Transaction Support Agreement (this ?Agreement?) is made and entered into as of March 16, 2022, by and among Bioceres Crop Solutions Corp., a Cayman Islands exempted company (?Parent?), BCS Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (?Merger Sub?), and the stockholders of Marrone Bio I |
|
March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
March 17, 2022 |
Exhibit 99.2 Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible notes into shares and new term loan facility ROSARIO, Argentina, and RALEIGH, N.C. ? March 16, 2022 ? Bioceres Crop Solutions Corp. (NASDAQ: |
|
March 17, 2022 |
Filed by Bioceres Crop Solutions Corp. (Commission File No. 001-38836) Pursuant to Rule 425 under the Securities Act of 1933 And Deemed Filed und Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Bioceres Crop Solutions Corp. Bioceres Crop Solutions Transaction Presentation This Presentation is for informational purposes only and does not constitute an offer or invitation to s |
|
February 25, 2022 |
? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argent |
|
February 25, 2022 |
Table of Contents ? ? ? BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2021 and June 30, 2021, and for the three-and six-month periods ended December 31, 2021, and 2020. ? ? ? ? ? ? ? Table of Contents INDEX ? ? ? Unaudited interim condensed consolidated financial statements as of December 31, 2021, June 30, 2021 and for the three- an |
|
February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
February 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2022 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 30, 2021 |
Form 6-K filed with the Commission on November 30, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 30, 2021 |
EX-99.1 2 tm2132584d3ex99-1.htm EXHIBIT 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of September 30, 2021 and June 30, 2021, and for the three-month periods ended September 30, 2021, and 2020. INDEX Unaudited interim condensed consolidated financial statements as of September 30, 2021, June 30, 2021 and for the three-month periods ended Septe |
|
November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
October 29, 2021 |
6-K 1 tm2119115d26k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant’s name into English) Ocampo 210 bis, Predio CCT, Rosari |
|
October 29, 2021 |
Exhibit 15.1 ? CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ? We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-249770) and Form S-8 (No. 333-255635) of Bioceres Crop Solutions Corp. of our report dated September 30, 2021 relating to the financial statements, which appears in this Form 20-F. ? ? /s/ Price Waterhouse & Co. S.R.L. /s/ |
|
October 29, 2021 |
Bioceres Crop Solutions Corp. holds its 2021 Annual Shareholders’ Meeting EXHIBIT 99.1 Bioceres Crop Solutions Corp. holds its 2021 Annual Shareholders? Meeting New York, New York / October 27, 2021 - Bioceres Crop Solutions Corp. (?Bioceres Crop Solutions,? the ?Company,? ?we,? ?us? or ?our?) (NASDAQ: BIOX) held its 2021 Annual Shareholders? Meeting (the ?Meeting?) at the Company?s legal counsel?s office in New York, NY and virtually. At the Meeting, the Company?s shar |
|
October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
October 29, 2021 |
Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Executive Officer Exhibit 12.1 ? CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 ? I, Federico Trucco, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or |
|
October 29, 2021 |
Rule 13a-14(a)/15d-14(a) -– Section 302 - Certification of Chief Financial Officer ? Exhibit 12.2 ? CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 ? I, Enrique L?pez Lecube, certify that: 1. I have reviewed this annual report on Form 20-F of Bioceres Crop Solutions Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material |
|
October 29, 2021 |
18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer Exhibit 13.1 ? CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ? In connection with the Annual Report of Bioceres Crop Solutions Corp. (the ?Company?) on Form 20-F for the year ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned hereby certifies pursuant t |
|
October 29, 2021 |
18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer Exhibit 13.2 ? CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ? In connection with the Annual Report of Bioceres Crop Solutions Corp. (the ?Company?) on Form 20-F for the year ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned hereby certifies pursuant t |
|
October 15, 2021 |
Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.0001 par value, of Bioceres Crop Solutions Corp. and further agree that this joint filing agreement be incl |
|
October 15, 2021 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a |
|
October 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina |
|
October 7, 2021 |
www.biocerescrops.com Ocampo 210 bis Predio CCT Rosario (2000) Rosario, Santa Fe, Argentina T: (54) 341 4861100 E: [email protected] / [email protected] September 30, 2021 Dear Shareholder, You are cordially invited to attend the 2021 Annual General Meeting (the ?Annual General Meeting?) of Bioceres Crop Solutions Corp. (the ?Company? or ?Bioceres Crop Solutions?) to b |
|
October 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
September 30, 2021 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2021, 2020 and 2019. INDEX Consolidated financial statements as of and for the years ended June 30, 2021, 2020 and 2019. Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-4 Consolidated statements of comprehensive income F-6 C |
|
September 30, 2021 |
Form 6-K filed with the Commission on September 30, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
September 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
September 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argenti |
|
August 6, 2021 |
BIOX / Bioceres Crop Solutions Corp. / Bioceres S.A. - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Bioceres Crop Solutions Corp. (Name of Issuer) Ordinary Shares, $0.0001 par value (Title of Class of Securities) G1117K 114 (CUSIP Number) Gloria Montaron Estrada Executive Director Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Name, Address a |
|
August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No. |
|
July 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No. |
|
June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
June 1, 2021 |
EX-99.1 2 tm2117492d1ex99-1.htm EXHIBIT 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2021, June 30, 2020 and for the nine-month periods ended March 31, 2021 and 2020. BIOCERES CROP SOLUTIONS CORP. INDEX Unaudited interim condensed consolidated financial statements as of March 31, 2021, June 30, 2020 and for the nine-month periods |
|
June 1, 2021 |
As filed with the Securities and Exchange Commission on May 28, 2021 As filed with the Securities and Exchange Commission on May 28, 2021 Registration No. |
|
May 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina (Ad |
|
April 30, 2021 |
Stand Alone Share Option Agreement between the Registrant and Jorge Wagner dated June 18, 2019. Exhibit 99.16 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Jorge Wagner ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions of |
|
April 30, 2021 |
Stand Alone Share Option Agreement between the Registrant and Natalia Zang dated April 14, 2019. Exhibit 99.20 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Natalia Zang ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions of |
|
April 30, 2021 |
Stand Alone Share Option Agreement between the Registrant and Federico Trucco dated June 18, 2019. Exhibit 99.14 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Federico Trucco ?Number of Shares Subject to Option?: 300,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions |
|
April 30, 2021 |
Exhibit 99.15 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Federico Trucco, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Ag |
|
April 30, 2021 |
EX-99.19 22 tm212929d5ex99-19.htm EXHIBIT 99.19 Exhibit 99.19 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Gerónimo Watson, as the Beneficiary, and Bioceres Crop Solutions Corp. (the “Company” and jointly with the Beneficiary referred to as the “Parties”) having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary |
|
April 30, 2021 |
Exhibit 99.3 BIOCERES CROP SOLUTIONS CORP. EMPLOYEE STOCK OPTION PLAN The Bioceres Crop Solutions Corp. Employee Stock Option Plan (this ?Plan?) was approved by the annual shareholders? meeting, dated October 28, 2020 (the ?Effective Date?) to provide an incentive to eligible employees of Bioceres Crop Solutions Corp. (the ?Company?) and its Subsidiaries, who are in a position to influence the per |
|
April 30, 2021 |
Stand Alone Share Option Agreement between the Registrant and Kyle Bransfield dated April 14, 2019. Exhibit 99.4 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Kyle P. Bransfield ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditio |
|
April 30, 2021 |
Exhibit 99.11 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Ari Freisinger, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Agr |
|
April 30, 2021 |
Exhibit 99.8 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Gloria Montaron Estrada ?Number of Shares Subject to Option?: 200,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4,55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and cond |
|
April 30, 2021 |
Exhibit 99.9 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Gloria Montar?n Estrada, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement ( |
|
April 30, 2021 |
Exhibit 99.12 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Enrique Lopez Lecube ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and condit |
|
April 30, 2021 |
Exhibit 99.13 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Enrique Lopez Lecube, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (th |
|
April 30, 2021 |
Exhibit 99.6 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Carlos Ivan Camargo de Col?n ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms an |
|
April 30, 2021 |
Exhibit 99.5 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Kyle P. Bransfield, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ? |
|
April 30, 2021 |
Exhibit 99.21 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Natalia Zang, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Agree |
|
April 30, 2021 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. EMPLOYEE STOCK PURCHASE PLAN The Bioceres Crop Solutions Corp. Employee Stock Purchase Plan (this ?Plan?) was approved by the annual shareholders? meeting, dated October 28, 2020 (the ?Effective Date?), to provide an incentive to eligible employees of the Bioceres Crop Solutions Corp. (the ?Company?) and its Subsidiaries. 1. Establishment of Plan The Comp |
|
April 30, 2021 |
Stand Alone Share Option Agreement between the Registrant and Ari Freisinger dated April 14, 2019. Exhibit 99.10 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Ari Freisinger ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: April 14, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions |
|
April 30, 2021 |
Exhibit 99.17 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Jorge Wagner, as the Beneficiary, and Bioceres Crop Solutions Corp. (the ?Company? and jointly with the Beneficiary referred to as the ?Parties?), having tis principal place of business at Ocampo 2 Obis, City of Rosario, Province of Santa Fe; and WHEREAS The Beneficiary entered into a Share Option Agreement (the ?Agree |
|
April 30, 2021 |
EX-99.7 10 tm212929d5ex99-7.htm EXHIBIT 99.7 Exhibit 99.7 AMENDMENT TO SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. Carlos Ivan Camargo de Colón, as the Beneficiary, and Bioceres Crop Solutions Corp. (the “Company” and jointly with the Beneficiary referred to as the “Parties”), having tis principal place of business at Ocampo 210bis, City of Rosario, Province of Santa Fe; and WHEREAS The B |
|
April 30, 2021 |
Exhibit 99.2 BIOCERES CROP SOLUTIONS CORP. EQUITY COMPENSATION PLAN The Bioceres Crop Solutions Corp. Equity Compensation Plan (the ?Plan?) was approved by the annual shareholders? meeting, dated October 31, 2019 (the ?Effective Date?), to provide long-term incentive compensation to the executive directors of the Board of Directors and certain key management members of Bioceres Crop Solutions Corp |
|
April 30, 2021 |
Stand Alone Share Option Agreement between the Registrant and Geronimo Watson dated June 18, 2019. Exhibit 99.18 SHARE OPTION AGREEMENT BIOCERES CROP SOLUTIONS CORP. ?Beneficiary?: Ger?nimo Watson ?Number of Shares Subject to Option?: 100,000 ordinary shares par value US$ 0.0001 per share ?Option Exercise Price? per each Share Subject to Option: US$ 4.55 ?Date of Grant?: June 18, 2019 ?Vesting Schedule?: Pursuant to Appendix I ?Expiration Date?: October 31, 2029. Under the terms and conditions |
|
April 30, 2021 |
Form S-8 (Registration No. 333-255635) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bioceres Crop Solutions Corp. (Exact name of registrant as specified in its charter) The Cayman Islands (State or other jurisdiction of incorporation or organization) N/A (I.R.S. Employer Identification No.) Ocampo 210 bis, Predio CCT, Rosario Province of Santa F |
|
April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. NYSE American (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) Ocampo 2 |
|
April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BIOCERES CROP SOLUTIONS CORP. (Exact name of Registrant as specified in Its Charter) Cayman Islands (State or other jurisdiction of incorporation or organization) Not Applicable (I.R.S. Employer Id |
|
April 14, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
April 14, 2021 |
Bioceres Crop Solutions Announces Transfer to Nasdaq Stock Market Exhibit 99.1 Bioceres Crop Solutions Announces Transfer to Nasdaq Stock Market ROSARIO, Argentina - April 14, 2021 - Bioceres Crop Solutions Corp. (?Bioceres? or the ?Company?) (NYSE American: BIOX), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today that it will voluntarily transfer its stoc |
|
March 16, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
March 4, 2021 |
Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina ( |
|
February 26, 2021 |
Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of December 31, 2020, June 30, 2020 and for the six-month periods ended December 31, 2020 and 2019. BIOCERES CROP SOLUTIONS CORP. INDEX Unaudited interim condensed consolidated financial statements as of December 31, 2020, June 30, 2020 and for the six-month periods ended December 31, 2020 a |
|
February 26, 2021 |
(c) the Registrant’s Report on Form 6-K filed with the Commission on February 26, 2021; and UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2021 Commission File Number: 001-38836 BIOCERES CROP SOLUTIONS CORP. (Translation of registrant?s name into English) Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentin |
|
February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |